U.S., July 14 -- ClinicalTrials.gov registry received information related to the study (NCT07697846) titled 'A Study to Investigate the Effects of Zovaglutide (ZT002 Injection) on QTc Interval in Healthy Adults' on June 29.

Brief Summary: This study is designed to investigate the effect of treatment with Zovaglutide (ZT002 Injection) on the corrected cardiac QT interval relative to a placebo control in healthy participants.

Study Start Date: July 18

Study Type: INTERVENTIONAL

Condition: Overweight, Obesity

Intervention: DRUG: ZT002 injection

Subjects will receive subcutaneous injections of Zovaglutide (ZT002 Injection) once every two weeks.

DRUG: ZT002 injection matching placebo

Subjects will receive subcutaneous injections of ZT0...